ClinicalTrials.Veeva

Menu
B

Boston Clinical Trials | Boston, MA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Rimegepant
Galcanezumab
Rapastinel
LY3526318
Troriluzole
LY3556050
LY3857210
BHV-7000
Enobosarm
Lorundrostat

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

30 of 160 total trials

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain (CPMP)

The purpose of the chronic pain master protocol is to compare independent pain interventions and establish an overarching structure for the disease-s...

Enrolling
Chronic Low-back Pain
Diabetic Neuropathic Pain
Drug: LY4065967 ISA
Drug: Placebo Oral
Status recently updated

This study evaluates the safety and efficacy of brenipatide (LY3537031) as an add on therapy in participants with major depression who still have sym...

Not yet enrolling
Enrolling
Major Depressive Disorder
Drug: Brenipatide
Drug: Placebo

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.Additional part...

Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo

The main purpose of this study is to evaulate the efficacy and safety of galcanezumab in participants 6 to 17 years of age for the preventive treatme...

Active, not recruiting
Episodic Migraine
Drug: Galcanezumab
Drug: Placebo
Locations recently updated

Orelabrutinib is a CNS-penetrable BTK inhibitor. This is a phase 3, randomized, double-blind, parallel-group, multicenter study to evaluate the effic...

Enrolling
Secondary Progressive Multiple Sclerosis
Drug: Placebo
Drug: Orelabrutinib

The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's...

Active, not recruiting
Alzheimer's Disease
Drug: Placebo
Drug: Remternetug

The purpose of this study is to understand the safety and effectiveness of the study drug, Dysport® when compared with placebo in preventing chronic...

Active, not recruiting
Chronic Migraine
Other: Placebo
Biological: Botulinum toxin type A

The purpose of this study is to understand the safety and effectiveness of the study drug, Dysport® when compared with placebo in preventing episodic...

Active, not recruiting
Episodic Migraine
Other: Placebo
Biological: Botulinum toxin type A

The primary purpose of this study is to evaluate the efficacy of centanafadine once daily (QD) extended-release (XR) capsules in adults with attentio...

Enrolling
Attention-deficit/Hyperactivity Disorder
Emotional Dysregulation
Drug: Centanafadine XR

This is a global, phase 3, randomized, double-blind, parallel-group, 3-arm, placebo-controlled, multicenter study designed to compare the efficacy, s...

Enrolling
Generalized Anxiety Disorder
Drug: SEP-363856
Other: Placebo

X-NOVA-OLE is a multicenter, open-label study to evaluate the long-term safety, tolerability, and efficacy of azetukalner as a monotherapy in adult p...

Active, not recruiting
Major Depressive Disorder
Drug: Azetukalner

The North Star study is a multi-center, Phase 3, open-label, single-arm clinical study to evaluate the Efficacy and Safety of North Star therapy.

Enrolling
Hypothyroidism
Drug: Desiccated Porcine Thyroid Extract Tablets
Locations recently updated

The aim of the trial is to prove the efficacy and safety of VER-01 compared to placebo in patients with chronic painful lumbosacral radiculopathy (PL...

Enrolling
Lumbosacral Radiculopathy
Other: Placebo
Drug: VER-01

The purpose of each study is to independently measure the annualized relapse rate (ARR) with administration of frexalimab compared to a daily oral do...

Active, not recruiting
Multiple Sclerosis
Drug: Activated charcoal
Drug: Cholestyramine

The purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the dis...

Active, not recruiting
Multiple Sclerosis
Drug: Frexalimab
Drug: Placebo

The main purpose of this study is to evaluate the safety and efficacy of nipocalimab compared to placebo in delaying relapse in adults with chronic i...

Enrolling
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Drug: Nipocalimab
Drug: Placebo

This is a phase 3, randomized, placebo-controlled study of the efficacy and safety of enlicitide decanoate, an oral proprotein convertase subtilisin/...

Active, not recruiting
Arteriosclerosis
Hypercholesterolaemia
Drug: Enlicitide Decanoate
Drug: Placebo

The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine in participants with pain associated with diabetic per...

Enrolling
Diabetic Peripheral Neuropathic Pain
Drug: Placebo (matched to SUZ)
Drug: Suzetrigine

A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsy

Invitation-only
Focal Epilepsy
Drug: BHV-7000

The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to \< 18...

Enrolling
Acute Treatment of Migraine
Drug: Rimegepant (PF-07899801)

Trial sponsors

Lilly logo
Pfizer logo
Biohaven logo
AbbVie logo
Allergan logo
Biohaven logo
Otsuka logo
Allergan logo
Shire logo
G

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems